← Back to Clinical Trials
Recruiting NCT06640205

NCT06640205 Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06640205
Status Recruiting
Phase
Sponsor Future University in Egypt
Condition Pulpotomy
Study Type INTERVENTIONAL
Enrollment 51 participants
Start Date 2023-09-03
Primary Completion 2024-09-02

Trial Parameters

Condition Pulpotomy
Sponsor Future University in Egypt
Study Type INTERVENTIONAL
Phase N/A
Enrollment 51
Sex ALL
Min Age 15 Years
Max Age 30 Years
Start Date 2023-09-03
Completion 2024-09-02
Interventions
pulpotomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Assessment of I-PRF versus Nano Mineral trioxide aggregate Combined with I-PRF in pulpotomy in mature Mandibular First Molars

Eligibility Criteria

Inclusion Criteria: * Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved. * Patients of either gender aged from 15-30. * Tooth should give positive response to cold test. * The tooth is restorable * Patients should be free from any systemic disease that may affect normal healing and predictable outcome. * Patients who will agree to the consent and will commit to follow-up period. * Patients with mature root. * Patients with no internal or external resorption and no periapical lesions. * Soft tissues around the tooth are normal with no swelling or sinus tract. Exclusion Criteria: * Patients with immature roots. * Haemostasias after 10 minutes can not be controlled after total pulpotomy * Patients with periapical lesions or infections. * Pregnant females. * Patients with fistula or swelling * Patients with necrotic pulp.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology